Table 1. Clinical characteristics of study participants by mortality.
Non-Survivors | Survivors | |
---|---|---|
n(%) | n(%) | |
Age (years) | ||
≤60 | 24 (35.8) | 64 (62.1) |
>60 | 43 (64.2) | 39 (37.9) |
Gender | ||
Male | 52 (77.6) | 81 (78.6) |
Female | 15 (22.4) | 22 (21.4) |
Symptoms | ||
Fever | 54 (80.6) | 86 (63.5) |
Cough | 40 (59.7) | 62 (60.2) |
SOB | 57 (85.1) | 83 (80.6) |
Runny nose | 1 (1.5) | 3 (2.9) |
Sore Throat | 3 (4.5) | 4 (3.9) |
Chest Pain | 5 (7.5) | 2 (1.9) |
Fatigue | 8 (11.9) | 5 (4.9) |
Diarrhea | 4 (6.0) | 8 (7.8) |
Vomiting | 2 (3.0) | 10 (9.7) |
Others | 13 (19.4) | 26 (25.2) |
Duration of symptoms* (days) | 6 (4–7) | 7 (4–10) |
Comorbid conditions | ||
None | 13 (19.4) | 38 (36.9) |
Hypertension | 35 (52.2) | 39 (37.9) |
Diabetes | 35 (52.2) | 41 (39.8) |
Liver Disease | 1 (1.5) | 0 (0) |
Lung Disease | 3 (4.5) | 3 (2.9) |
Renal Disease | 6 (9.0) | 7 (6.8) |
Heart Disease | 7 (10.4) | 10 (9.7) |
Other | 12 (17.9) | 26 (25.2) |
Number of comorbid conditions | ||
< = 2 | 43 (79.6) | 45 (69.2) |
3 or more | 11 (20.4) | 20 (30.8) |
Clinical Signs at presentation | ||
Systolic Blood pressure* (mm/Hg) | 144 (123–159) | 135 (122–149) |
Diastolic Blood pressure* (mm/Hg) | 80 (68.5–95) | 79 (72.5–89) |
Pulse**/minute | 104.0 ± 22.0 | 101.1 ±20.3 |
Respiratory Rate*/m | 32 (26–38) | 28 (23–32) |
Temperature* °F | 98.6 (98–99.0) | 98.4 (98–98.6) |
Oxygen Saturation (%) | ||
≥93% | 13 (19.4) | 46 (44.7) |
<93% | 54 (80.6) | 57 (51.4) |
Glasgow Coma Scale | 15 (15–15) | 15 (15–15) |
Disease Severity | ||
Moderate | 0 (0) | 18 (17.5) |
Severe | 3 (4.5) | 12 (11.7) |
Critical | 64 (95.5) | 73 (70.9) |
Non-invasive ventilation in emergency room | ||
Yes | 38 (56.7) | 27 (26.2) |
No | 29 (43.3) | 76 (73.8) |
Clinical Severity Scores | ||
SOFA score* | 6 (5–8.2) | 4 (4–6) |
CURB-65 score* | 2 (1–3) | 1 (0–2) |
MuLBSTA* | 7.5 (6–9.5) | 5 (2–8) |
Month of admission | ||
March | 4 (5.9) | 2 (1.9) |
April | 22 (32.8) | 28 (27.4) |
May | 32 (47.8) | 46 (45.1) |
June | 9 (13.4) | 26 (25.5) |
*Median (Q1-Q3)
**Mean±SD.